Literature DB >> 30143577

Presynaptic Inhibition of Primary Nociceptive Signals to Dorsal Horn Lamina I Neurons by Dopamine.

Yong Lu1, Maksym Doroshenko1, Justas Lauzadis1, Martha P Kanjiya1, Mario J Rebecchi1, Martin Kaczocha1, Michelino Puopolo2.   

Abstract

The dorsal horn of the spinal cord represents the first relay station in the pain pathway where primary nociceptive inputs are modulated by local circuits and by descending signals before being relayed to supraspinal nuclei. To determine whether dopamine can modulate primary nociceptive Aδ- and C-fiber signals, the effects of dopamine were tested on the excitatory postsynaptic currents (EPSCs) recorded from large lamina I neurons and from retrograde-labeled spinoparabrachial lamina I neurons upon stimulation of the L4/L5 dorsal root in horizontal spinal cord slices in vitro Dopamine inhibited the EPSCs in a dose-dependent manner, with substantial inhibition (33%) at 1 μm and maximum inhibition (∼70%) at 10-20 μm Dopamine reduced the frequency of miniature EPSCs recorded from large lamina I neurons, increased the paired pulse depression ratio of paired EPSCs, and induced similar inhibition of EPSCs after dialysis of large lamina I neurons with GDP-β-S, consistent with actions at presynaptic sites. Pharmacological experiments suggested that the inhibitory effects of dopamine were largely mediated by D4 receptors (53%). Similar inhibition (66%) by dopamine was observed on EPSCs recorded from ipsilateral large lamina I neurons 6 d after injection of complete Freund's adjuvant in the hindpaw, suggesting that dopamine downregulates primary nociceptive inputs to lamina I neurons during chronic inflammatory pain. We propose that presynaptic inhibition of primary nociceptive inputs to lamina I projection neurons is a mechanism whereby dopamine can inhibit incoming noxious stimuli to the dorsal horn of the spinal cord.SIGNIFICANCE STATEMENT Lamina I projection neurons represent the main output for the pain signals from the dorsal horn of the spinal cord to brainstem and thalamic nuclei. We found that dopamine inhibits the nociceptive Aδ- and C-fiber synaptic inputs to lamina I projection neurons via presynaptic actions. Similar inhibitory effects of dopamine on the EPSCs were observed in rats subjected to complete Freund's adjuvant to induce peripheral inflammation, suggesting that dopamine inhibits the synaptic inputs to lamina I neurons in the setting of injury. A better understanding of how primary nociceptive inputs to the dorsal horn of the spinal cord are modulated by descending monoaminergic signals may help in the development of new pharmacological strategies to selectively downregulate the output from lamina I projection neurons.
Copyright © 2018 the authors 0270-6474/18/388809-13$15.00/0.

Entities:  

Keywords:  D4 receptors; dopamine; dorsal horn spinal cord; lamina I neurons; nociception

Mesh:

Substances:

Year:  2018        PMID: 30143577      PMCID: PMC6596087          DOI: 10.1523/JNEUROSCI.0323-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  87 in total

Review 1.  Descending control of pain.

Authors:  Mark J Millan
Journal:  Prog Neurobiol       Date:  2002-04       Impact factor: 11.685

2.  D1-like dopamine receptors selectively block P/Q-type calcium channels to reduce glutamate release onto cholinergic basal forebrain neurones of immature rats.

Authors:  Toshihiko Momiyama; Yugo Fukazawa
Journal:  J Physiol       Date:  2007-01-18       Impact factor: 5.182

3.  Aberrant synaptic integration in adult lamina I projection neurons following neonatal tissue damage.

Authors:  Jie Li; Elizabeth Kritzer; Paige E Craig; Mark L Baccei
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

4.  Levodopa analgesia in experimental neuropathic pain.

Authors:  Nuria Cobacho; José L De la Calle; José R González-Escalada; Carlos L Paíno
Journal:  Brain Res Bull       Date:  2010-09-09       Impact factor: 4.077

5.  Two distinct modulatory effects on calcium channels in adult rat sensory neurons.

Authors:  A Formenti; E Arrigoni; M Mancia
Journal:  Biophys J       Date:  1993-04       Impact factor: 4.033

6.  Dopamine D(2)-like receptors selectively block N-type Ca(2+) channels to reduce GABA release onto rat striatal cholinergic interneurones.

Authors:  T Momiyama; E Koga
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

7.  Voltage-dependent calcium channels in rat midbrain dopamine neurons: modulation by dopamine and GABAB receptors.

Authors:  D L Cardozo; B P Bean
Journal:  J Neurophysiol       Date:  1995-09       Impact factor: 2.714

8.  Dopamine inhibits mitral/tufted--> granule cell synapses in the frog olfactory bulb.

Authors:  Ian G Davison; Jamie D Boyd; Kerry R Delaney
Journal:  J Neurosci       Date:  2004-09-15       Impact factor: 6.167

9.  Neurons of the dopaminergic/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the trigeminocervical complex: an electrophysiological and immunohistochemical study.

Authors:  Annabelle R Charbit; Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

10.  Presynaptic and postsynaptic mechanisms underlie paired pulse depression at single GABAergic boutons in rat collicular cultures.

Authors:  Sergei Kirischuk; John D Clements; Rosemarie Grantyn
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

View more
  8 in total

1.  Gain control in the sensorimotor system.

Authors:  Eiman Azim; Kazuhiko Seki
Journal:  Curr Opin Physiol       Date:  2019-03-22

2.  Methylphenidate and Morphine Combination Therapy in a Rat Model of Chronic Pain.

Authors:  Zerong You; Weihua Ding; Jason T Doheny; Shiqian Shen; Jinsheng Yang; Liuyue Yang; Lucy Chen; Shengmei Zhu; Jianren Mao
Journal:  Anesth Analg       Date:  2020-02       Impact factor: 5.108

3.  Anthrax toxins regulate pain signaling and can deliver molecular cargoes into ANTXR2+ DRG sensory neurons.

Authors:  Nicole J Yang; Jörg Isensee; Dylan V Neel; Andreza U Quadros; Han-Xiong Bear Zhang; Justas Lauzadis; Sai Man Liu; Stephanie Shiers; Andreea Belu; Shilpa Palan; Sandra Marlin; Jacquie Maignel; Angela Kennedy-Curran; Victoria S Tong; Mahtab Moayeri; Pascal Röderer; Anja Nitzsche; Mike Lu; Bradley L Pentelute; Oliver Brüstle; Vineeta Tripathi; Keith A Foster; Theodore J Price; R John Collier; Stephen H Leppla; Michelino Puopolo; Bruce P Bean; Thiago M Cunha; Tim Hucho; Isaac M Chiu
Journal:  Nat Neurosci       Date:  2021-12-20       Impact factor: 28.771

4.  D1/D5 Dopamine Receptors and mGluR5 Jointly Enable Non-Hebbian Long-Term Potentiation at Sensory Synapses onto Lamina I Spinoparabrachial Neurons.

Authors:  Jie Li; Theodore J Price; Mark L Baccei
Journal:  J Neurosci       Date:  2021-11-23       Impact factor: 6.709

5.  Spinal cord injury alters spinal Shox2 interneurons by enhancing excitatory synaptic input and serotonergic modulation while maintaining intrinsic properties in mouse.

Authors:  D Leonardo Garcia-Ramirez; Ngoc T B Ha; Steve Bibu; Nicholas J Stachowski; Kimberly J Dougherty
Journal:  J Neurosci       Date:  2021-05-13       Impact factor: 6.167

6.  Deep sequencing analysis to identify novel and rare variants in pain-related genes in patients with acute postoperative pain and high morphine use.

Authors:  Mun-Fai Loke; Heming Wei; Junjie Yeo; Ban-Leong Sng; Alex T Sia; Ene-Choo Tan
Journal:  J Pain Res       Date:  2019-09-19       Impact factor: 3.133

7.  Pre-Synaptic GABAA in NaV1.8+ Primary Afferents Is Required for the Development of Punctate but Not Dynamic Mechanical Allodynia following CFA Inflammation.

Authors:  Sheng Liu; Veronica Bonalume; Qi Gao; Jeremy Tsung-Chieh Chen; Karl Rohr; Jing Hu; Richard Carr
Journal:  Cells       Date:  2022-08-03       Impact factor: 7.666

8.  D2 receptor activation relieves pain hypersensitivity by inhibiting superficial dorsal horn neurons in parkinsonian mice.

Authors:  Dong-Liang Tang; Yi-Wen Luan; Chun-Yi Zhou; Cheng Xiao
Journal:  Acta Pharmacol Sin       Date:  2020-07-21       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.